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▼The green fluorescent protein (GFP) of the jellyfish Ae-
quorea victoria has autofluorescence characteristics that
make it a powerful reagent in the study of gene expression
and organelle structure within living cells. Extensive muta-
genesis of the original gene has been used to select GFP vari-
ants with increased fluorescence intensity as well as those
withmodified excitation- and emission-wavelength charac-
teristics. Bettermammalian expression has been attained by
‘humanizing’ the codon usage in the gene’s sequence and
the discovery of newmutant alleles whose protein products
fold more efficiently at 37 ◦C (Ref. 1, 2, 3, 4, 5, 6).
Fusion of GFP to the coding sequences of various genes
has been used extensively to determine the subcellular lo-
calization and behavior of proteins in live cells using flu-
orescence microscopy (Ref. 7). Modification of GFP by the
addition of targeting sequences has been used to distinguish
and identify various cellular organelles (Ref. 8). In addition,
variant GFP alleles with enhanced fluorescence character-
istics, EGFP, have been useful in flow cytometric analysis
of living cells (Ref. 9, 10). We sought to take advantage of
this application by using EGFP as a marker to distinguish
transfected cell populations in conjunction with routinely
used propidium iodide DNA staining procedures that re-
quire ethanol fixation of cells.
Expression of cell-surface proteins, such as CD20, is com-
monly used as a cotransfection marker in procedures that
use propidium iodide staining to determine the cell-cycle
distribution of transiently transfected cells by flow cytome-
try (Ref. 11). This method has been used extensively to de-
termine the effects of overexpressing various regulators of
cell cycle progression (Ref. 12, 13) and involves the transfec-
tion of the desired expression plasmid along with a CD20
expression construct. The cells are stained with an anti-
CD20 fluorescent-conjugated monoclonal antibody and
permeabililzed by ethanol fixation to permit DNA stain-
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ing with propidium iodide. Flow cytometry can then be
used to examine the DNA content, and hence to determine
the cell-cycle distribution of individual transfected cells by
’gating’ or selecting for the anti-CD20 fluorescent cell pop-
ulation. In order to eliminate the immunological staining
step, we performed similar experiments using an EGFP ex-
pression construct (Clontech) as a transfection marker. Our
preliminary results demonstrated that, although EGFP was
expressed and autofluoresced in live transfected cells, the
fluorescence signal was lost after the ethanol-fixation step
(data not shown). We deduced that this ethanol-induced
loss of fluorescence was because of the denaturation or loss
of the EGFP protein from the cells upon fixation. The crystal
structure of GFP and description of the fluorescence mecha-
nism suggested that ethanol would not quench the activity
of GFP (Ref. 14, 15, 16). Indeed, the treatment of purified
GFP protein (Clontech) with 70% ethanol did not result
in the loss of its autofluorescence capacity, as determined
by fluorescence microscopy (data not shown). This led us
to postulate that the GFP protein was being released upon
permeabilization of cells using ethanol treatment.
In order to increase the retention of GFP within cells, we
opted to fuse the EGFP coding sequence to a nuclear local-
ization signal derived from the SV40 large tumor antigen
(Ref. 17). This signal has been used to direct the localiza-
tion of various proteins into the cell nucleus. The new EGFP
variant, EGFPNL, was placed under the control of the CMV
promoter in the mammalian expression vector, p cDNA
3 (Invitrogen). These expression vectors were then trans-
fected into U2os osteosarcoma cells (ATCC number HTB-
96) grown on coverslips and visualized by fluorescence mi-
croscopy. Upon viewing of live cells, EGFP was expressed
well and was distributed evenly throughout the transfected
cells (Fig. 1a), whereas the EGFPNL protein appeared to con-
centrate within the cells’ nucleus (Fig. 1d). Upon ethanol
fixation of transfected cultures, the EGFP fluorescence sig-
nal was no longer visible (Fig. 1c). The EGFPNL protein,
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FIGURE 1. Microscopic examination of green fluorescent protein (GFP) expressing cells. U2os osteosarcoma cells (ATCC number HTB-96) were
transfected with mammalian expression plasmids containing either EGFP (a, b and c) or EGFPNL (d, e and f) cDNAs. Transfected cells expressing GFP
were visualized by fluorescence microscopy before (a and d) or after (c and f) ethanol fixation, or by phase contrast microscopy (b and e). Magnification
values were 400×.
however, remained associated with the cells and its fluores-
cence signal was clearly visible in the nucleus of transfected
cells (Fig. 1f). Therefore, it appears that nuclear targeting of
EGFP can increase its cellular retention upon ethanol fix-
ation. Interestingly, cytoplasmic fluorescence of EGFPNL
was also evident after ethanol fixation. This might repre-
sent a proportion of this protein that can diffuse out of the
nucleus upon fixation.
Based on these results, we sought to establish the util-
ity of EGFPNL fluorescence in flow cytometry applications.
U2os osteogenic sarcoma cells transfectedwith either 1.0µg
of EGFP or EGFPNL expression plasmids were harvested 24
hours post transfection, fixed using 80% ethanol and ana-
lyzed by flow cytometry. Comparison of fluorescence his-
tograms of these U2os cells demonstrated that the EGFP-
transfected population (red, Fig. 2a) had aminor shift in flu-
orescence with a small shoulder of brightly fluorescent cells,
as compared with the mock-transfected population (blue,
Fig. 2a). The EGFPNL-transfected cells, however, demon-
strated a ten-fold shift in fluorescence over the mock trans-
fected population (green, Fig. 2a). The use of 2.5 µg of
EGFPNL plasmid in the transfection protocol resulted in
a further four-fold increase in the fluorescence intensity as
compared with mock-transfected cells (data not shown).
These results indicate that the intensity of fluorescence is
partly dependent on the amount of EGFPNL expressed in
the transfected cells.
We next examined EGFPNL expression in conjunction
with propidium iodide staining to analyze cell-cycle distri-
bution using fluorescence to identify the transfected cell
population. For these studies, cells were cotransfected with
the EGFPNL plasmid alongwith expression vectors contain-
ing various cDNAs (see Table 1). After 24 h, the cells were
fixed with 80% ethanol and analyzed by flow cytometry
following propidium iodide staining of DNA. These con-
structs were chosen based on the effects that each gene has
been shown to exert on the cell-cycle distribution of trans-
fected cells. For example, it has previously been shown that
the expression of a non-degradable form of cyclin B arrests
cell-cycle progression in mitosis because the destruction of
this cyclin is a prerequisite for exit from this phase of the
cell cycle (Ref. 18, 19). As seen in Fig. 2c, cotransfection
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FIGURE 2. GFP fluorescence utility in flow cytometry. (a) U2os cells transfected with EGFP (red trace) or EGFPNL (green trace) expression plasmids
were fixed and the fluorescence intensity profile determined by flow cytometry as described in the text. (b) and (c) U2os cells transfected with EGFPNL
and cyclin BN88 (see text) cDNA containing expression plasmids were fixed and stained with propidium iodide. (b) the flow cytometry histogram of
the total cell population, based on propidium iodide fluorescence. (c) the profile for the EGFPNL-expressing cell population after gated selection of these
cells as described in the text.
of a truncated cyclin B1 (pcDNA BN88) along with the
EGFPNL expression plasmid caused a dramatic increase in
the percentage of cells with a 4C DNA content, compared
with the ungated population of these same cells (Fig. 2b).
This indicates that these cells were blocked inmitosis. Table
1 also shows that expression of the p16INK4a gene product
in U2os and NCI-H1299 non-small cell lung cancer cells
(ATCC number CRL-5803) approximately doubled the pop-
ulation of cells in the G1 phase of the cell cycle. In addition,
expression of the retinoblastoma gene product in Saos-2 os-
teosarcoma cells (ATCC number HTB-85) resulted in a dra-
matic increase in cells displaying a 2C DNA content. These
results are consistent with results reported previously, using
CD20 as the marker for identification of transfected cells in
similar flow cytometry studies (Ref. 11, 12), and demon-
strate the utility of EGFPNL as a transfection marker in cells
that are arrested at various stages of the cell cycle.
We have described a novel use for the green fluorescent
protein that replaces the use of cell-surface proteins asmark-
ers for identification of transfected cell populations. The
value of GFP as an inert marker is demonstrated by the fact
that its expression does not appear to cause any adverse cel-
lular effects. The new EGFPNL construct removes the vari-
ability of the immunological staining process, is compatible
with ethanol fixation, and is useful in streamlining the
protocol for flow cytometric analysis of transfected cell
populations with a standard 488 nm argon laser cytometer.
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Table 1. Appropriate cells in culture were
cotransfected with the indicated cDNA the
EGFPNL expression plasmids. The cell-cycle
distribution of the transfected cells was determined
through selection of the EGFPNL fluorescent cells
upon propidium iodide staining and flow cytometry.
Cell line Construct %G0−G1 %S %G2−M
U2OS pCDNA vector 39 26 25
U2OS pCDNA BN88 11 20 69
U2OS pCMV 34 37 29
U2OS pCMV p16 58 30 12
SAOS2 pCMV 34 33 33
SAOS2 pCMV RB 70 21 9
H1299 pCDNA 41 46 13
H1299 pCDNA p16 74 15 11
Materials and methods
Vector construction
A BamH1-NotI fragment of pEGFP (Clontech) was cloned
into a pcDNA3 vector containing the nuclear localization
signal from SV40 T antigen (PKRKSAV) (Ref. 17).
Cell culture and microscopy
All cell lines were obtained from the American Type Culture
Collection and grown in DMEM high glucose media (Gibco
BRL) supplemented with 10% fetal bovine serum. U2os cells
were plated onto coverslips and transfected with 5 µg of
EGFP or EGFPNLDNAusing the calciumphosphatemethod
(Ref. 20). Coverslips were viewed live or were fixed in 2 ml
of ice-cold 80% ethanol. Fluorescent and transmitted light
images were acquired using a Cooled CCD camera with a
Axiovert 100TV microscope (Zeiss). Fluorescence filter sets
had an excitation wavelength of 480 nM, dichroic cut-on
filter at 505 nM and an emmision filter at 535 nM.
Flow cytometry
Cells were transfected with 2 µg of pEGFP and pEGFPNL
DNA and then harvested 24 h later in PBS, without calcium
and magnesium, containing 5 mM EDTA. The samples
were fixed and stained with propidium iodide as previously
described (Ref. 11). The samples were run on a Becton
Dickenson FacsCaliber flow cytometer and 10,000 events
were collected and analyzed for the FL1 fluorescence. Cell
Cycle effects were measured by cotransfecting 2 µg of
pEGFPNL and 5−10 µg of expression plasmids containing
the retinoblastoma gene (RB), p16INK4a, or amino-terminal
truncated cyclin B (BN88) cDNAs. Samples were stained
as above and 5,000 of the brightest events were gated and
collected. Cell-cycle profiles were analyzed using ModFit
software (Verity). The values are representative numbers of
two to five experiments with each construct.
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Products Used
GFP protein: GFP protein from Clontech Inc
cDNA: cDNA from Clontech Inc
pEGFP: pEGFP from Clontech Inc
glucose: glucose from Merck
Glucose: Glucose from Sigma
glucose: glucose from Merck
microscope (Stemi 2000): microscope (Stemi
2000) from Leica Microscopy & Scientific Instruments
Group
microscope: microscope from Carl Zeiss
ModFit Software: ModFit Software from Verity
Software House Inc
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